Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaroh Yamamoto

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Gastroenterology|July 14, 2010
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCCKentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama, et al.
Journal of Gastroenterology|December 17, 2022
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Helicobacter|December 28, 2020
Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Gastroenterology|July 14, 2010
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCCKentaroh Yamamoto, Hiroshi Imamura, Yutaka Matsuyama, et al.
Journal of Gastroenterology|December 17, 2022
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Helicobacter|December 28, 2020
Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Pageof 2